Physician profile
John Barcel
NPI 1518452473
$3,418.28
in general payments reported to CMS, 2019-2025
12 companies · $573 in 2025
The $573 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.07 · 2020: $229 · 2021: $1,800 · 2022: $278 · 2023: $519 · 2025: $573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565 · Travel and Lodging: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.65 |
| Travel and Lodging | $527.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $1,285.49 | 2021-2023 | |
| Stryker Corporation | $527.67 | 2025 | Mako |
| Depuy Synthes Sales INC. | $449.66 | 2020-2023 | Na |
| Axogen | $428.02 | 2021-2023 | Avance Nerve Graft |
| Integra Lifesciences Corporation | $151.90 | 2021 | |
| Treace Medical Concepts, INC. | $151.17 | 2021 | |
| Alafair Biosciences, INC. | $119.02 | 2023 | Versawrap |
| Kerecis Limited | $118.43 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Acumed LLC | $109.42 | 2020 | |
| Cgg Medical INC | $45.61 | 2025 | |
| Biomarin Pharmaceutical INC. | $19.07 | 2019 | |
| Teleflex LLC | $12.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Barcel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.